|
MYH9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.95840027422878E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63646873829748E-12 |
| Normal-vs-Stage2 |
3.07209999994562E-06 |
| Normal-vs-Stage3 |
6.377600E-03 |
| Normal-vs-Stage4 |
1.66504999999928E-05 |
| Stage1-vs-Stage2 |
5.055800E-01 |
| Stage1-vs-Stage3 |
2.135600E-02 |
| Stage1-vs-Stage4 |
5.083400E-01 |
| Stage2-vs-Stage3 |
1.546780E-01 |
| Stage2-vs-Stage4 |
3.643400E-01 |
| Stage3-vs-Stage4 |
7.564200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.48230366554026E-11 |
| Normal-vs-AfricanAmerican |
1.63099977967818E-10 |
| Normal-vs-Asian |
5.028800E-04 |
| Caucasian-vs-AfricanAmerican |
7.102400E-01 |
| Caucasian-vs-Asian |
5.668400E-01 |
| AfricanAmerican-vs-Asian |
5.975200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.03848049551425E-12 |
| Normal-vs-Female |
3.5561999999989E-05 |
| Male-vs-Female |
4.384400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.16419999593742E-08 |
| Normal-vs-Extreme_Weight |
1.16250342685476E-11 |
| Normal-vs-Obese |
2.24169999999413E-05 |
| Normal-vs-Extreme_Obese |
1.8236999999921E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.693800E-01 |
| Normal_Weight-vs-Obese |
1.307620E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.754800E-01 |
| Extreme_Weight-vs-Obese |
1.396410E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.040800E-01 |
| Obese-vs-Extreme_Obese |
2.008800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.004300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.6406000053214E-08 |
| Normal-vs-Age(61-80Yrs) |
1.08357767203415E-13 |
| Normal-vs-Age(81-100Yrs) |
9.08049999970295E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.025980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.406000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.658400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.351700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.117900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.622200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
9.73210000365654E-08 |
| Normal-VS-KIRP CIMP |
5.940000E-01 |
| Normal-VS-Unclassified PRCC |
9.181400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.781240E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.261600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.262500E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.400300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.202980E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.168810E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.35679999996508E-06 |
| Normal-vs-N1 |
6.414300E-04 |
| Normal-vs-N2 |
8.009000E-01 |
| N0-vs-N1 |
5.107000E-01 |
| N0-vs-N2 |
9.420300E-02 |
| N1-vs-N2 |
1.813240E-01 |
|
|
